Occipital Nerve Stimulation for Medically Refractory Chronic Paroxysmal Hemicrania.
Headache
; 57(10): 1610-1613, 2017 Nov.
Article
en En
| MEDLINE
| ID: mdl-28980700
ABSTRACT
OBJECTIVE:
To describe the outcome of a patient with refractory chronic paroxysmal hemicrania (CPH) to occipital nerve stimulation (ONS).BACKGROUND:
CPH is a primary headache disorder exquisitely sensitive to indomethacin. In patients unable to tolerate indomethacin, the therapeutic options are limited. ONS is a promising therapy for other refractory headache conditions. We report the first patient with medically refractory CPH treated with ONS.METHODS:
Following implantation of the occipital nerve stimulator in 2006, the patient kept prospective headache diaries. Outcome was assessed by daily attack frequency.RESULTS:
After a follow-up of over 10 years, the patient reported a sustained efficacy of more than 50% reduction in attack frequency and was pain-free at final follow-up. The patient was able to stop indomethacin completely. The patient had three successful pregnancies during follow-up. One system revision was undertaken alongside an expected battery replacement to treat unequal paresthesia and pain over the electrodes.CONCLUSION:
ONS may offer an effective long-term treatment for CPH in patients where indomethacin cannot be tolerated.Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Terapia por Estimulación Eléctrica
/
Hemicránea Paroxística
/
Neuroestimuladores Implantables
Tipo de estudio:
Observational_studies
/
Prognostic_studies
Límite:
Adult
/
Female
/
Humans
Idioma:
En
Revista:
Headache
Año:
2017
Tipo del documento:
Article
País de afiliación:
Reino Unido